Epelman, S., Mutran, T. M., Oliveira, R. D. P. G. D., Filho, N. P. D. C., Gorender, E. (2026). Bridging the access gap: First-line blinatumumab for KMT2A-rearranged infant acute lymphoblastic leukemia (ALL) in a public health system.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e23441